A new study published in the science journal Emerging Infectious Diseases reports that two individuals in Kenya have tested positive for the presence of antibodies to Middle East Respiratory Syndrome Corona Virus (MERS-CoV). Neither person is ill nor do they recall having any symptoms associated with MERS. There is no evidence of a public health threat and scientists concluded that the infections caused little or no clinical signs of illness. But they plan follow-up studies, as this is the first indication of a MERS-CoV infection that is not connected to primary infections in the Middle East.
Among short presentations made to Sir Mark Walport, the UK chief scientific adviser, on his 15 Jul 2015 tour of the biosciences laboratories at the International Livestock Research Institute (ILRI), in Nairobi, Kenya, was one by Joerg Jores, a molecular biologist working to better control important livestock diseases of Africa and other developing regions. Jores is a senior scientist in ILRI’s Vaccine Biosciences program whose work supports the CGIAR Research Program on Livestock and Fish.
Two new papers on MERS (Middle Eastern respiratory syndrome) coronavirus and camels in Eastern Africa have been published in the science journal ‘Emerging Infectious Diseases’; three of the authors are ILRI scientists.